Shoulder Innovations to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
Rhea-AI Summary
Shoulder Innovations (NYSE:SI), a commercial-stage medical technology company focused on shoulder surgical care, announced that its management will participate in the Goldman Sachs 47th Annual Global Healthcare Conference in Miami Beach, FL on Tuesday, June 9, 2026.
Positive
- None.
Negative
- None.
News Market Reaction – SI
In the May 27 session, SI declined 0.60%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| May 13 | Q1 2026 earnings | Positive | +15.2% | Strong Q1 revenue growth, margin expansion, and raised 2026 outlook. |
| Apr 27 | Product launch | Positive | +4.3% | Full commercial launch of InSet I-135RFX humeral stem with expanded use. |
| Apr 22 | Earnings date notice | Neutral | -4.5% | Announcement of timing for Q1 2026 financial results and call. |
| Mar 10 | FY 2025 earnings | Positive | +7.4% | Strong Q4 and full-year 2025 revenue growth with 2026 guidance issued. |
| Mar 2 | Board change | Neutral | -0.2% | Appointment of medtech veteran to board and related director resignation. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Shares have tended to react positively to earnings and product launch news, while scheduling and management updates have seen flat to negative moves.
This announcement about participating in a major healthcare conference follows a period of strong operational updates. Recent quarters showed robust revenue growth and higher gross margins, with guidance raised for 2026. The company has been expanding its shoulder implant portfolio, including a full commercial launch of the InSet™ I-135RFX stem, and adding experienced leadership to the board. Compared with these financially and commercially significant catalysts, this conference appearance is a routine investor-relations event.
AI-generated analysis. How Rhea-AI works. Not financial advice.
About Shoulder Innovations
Shoulder Innovations is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, with a current offering of advanced implant systems for shoulder arthroplasty. These systems are a core element of Shoulder Innovations' ecosystem, which is designed to improve core components of shoulder surgical care – preoperative planning, implant design and procedural efficiency – to benefit each stakeholder in the care chain. Shoulder Innovations' ecosystem is also comprised of enabling technologies, efficient instrument systems, specialized support and surgeon-to-surgeon collaboration. Together, these elements seek to address the long-standing clinical and operational challenges in the shoulder surgical care market by delivering predictable outcomes, procedural simplicity, and efficiency across all sites of care.
Contact
Brian Johnston or Sam Bentzinger
Gilmartin Group LLC
ir@shoulderinnovations.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/shoulder-innovations-to-participate-in-the-goldman-sachs-47th-annual-global-healthcare-conference-302782176.html
SOURCE Shoulder Innovations